Related Experiment Videos
Therapeutic approaches for memory impairments
1HOECHST AG, General Pharmacology Research, Pharmacological Screening, Frankfurt/M., Germany.
Behavioural Brain Research
|January 23, 1995
Summary
This review details pharmacological treatments for dementia, focusing on key drug classes like cholinesterase inhibitors and vasodilators. It highlights specific compounds to manage cognitive decline in dementia disorders.
Area of Science:
- Pharmacology
- Neuroscience
- Geriatrics
Background:
- Dementia disorders present significant challenges in cognitive decline and patient management.
- Effective pharmacological interventions are crucial for improving quality of life in dementia patients.
Purpose of the Study:
- To review and describe various pharmacological treatment strategies for dementia disorders.
- To provide a detailed overview of selected drug classes and specific compounds used in dementia therapy.
Main Methods:
- Literature review and synthesis of existing research on dementia pharmacotherapy.
- Detailed description of 15 classes of pharmacological agents, with a focus on selected examples.
Main Results:
- The study describes piracetam-type compounds, co-dergocrine-type compounds, vasodilators, haemorheological agents, cholinesterase inhibitors, ACTH and vasopressin analogs, and angiotensin II/ACE inhibitors.
- Specific compounds such as propentofylline, vincamine, THA, and RA-octil are discussed in detail.
Conclusions:
- Pharmacological approaches offer diverse strategies for managing dementia symptoms.
- Further research into specific drug classes and compounds can optimize dementia treatment protocols.